A Clinical Monte Carlo Dosimetric Evaluation in Accelerated Partial Breast Electronic Brachytherapy

C. Cheng,C. Shi,B. Guo,N. Papanikolaou,S. Ahmad
DOI: https://doi.org/10.1016/j.ijrobp.2008.06.041
2008-01-01
Abstract:Electronic brachytherapy has been recently utilized in accelerated partial breast irradiation. Deficient tissue inhomogeneity correction in the dose calculation draws physicians' attentions. In this study, a clinical Monte Carlo based dose evaluation was assessed to demonstrate these dosimetric impacts. The dosimetric characteristics of Xoft S700 Axxent X-ray source (Xoft, Fremont, CA) were first evaluated using EGS4 Monte Carlo code to verify the calculation model and source parameter accuracy. A whole body female photographic phantom with defined structures derived from National Library of Medicine's Visible Human Project utilizing all clinical parameters was then used in the dose calculation. A 5cm diameter spherical balloon was inserted in the right breast of the phantom. The volume expanded 1cm from the balloon surface was designed to define as planning target volume (PTV). The prescribed dose per fraction was 3.4 Gy to 5 user-selected points (anterior, posterior, right lateral, superior and inferior) of the PTV. Dose, dose volume histograms of the PTV and normal tissues, isodose distributions in axial, sagittal and coronal planes crossing the center of the balloon were evaluated. Using measured 50 kVp source spectrum provided by Xoft Inc, the simulated radial dose function agrees well with the published data within 3%. After corrected for vender addressed 6% balloon attenuation, the PTV dose reported from the commercial treatment planning system is within 1% compared to our calculation result. The simulation shows 100% PTV covered by 90.6% of the prescription dose with excellent dose uniformity. When accounted for the tissue heterogeneity, changes in the isodose distribution were clearly observed. The two dimensional dose distributions show high skin and rib doses due to photoelectric effect with reasonably acceptable doses to all other surrounding normal tissues. Our preliminary EGS4 Monte Carlo simulation study demonstrates the dosimetric impact in the electronic brachytherapy, especially on the surrounding normal tissues, when tissue inhomogeneity consideration is taken into account.
What problem does this paper attempt to address?